Clinical Trial Update: Phase II Study of Docetaxel Plus CDDP for NSCLC Stage III [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase II study evaluating docetaxel plus cisplatin for stage III non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: NSCLC | Phase 2 | Status: COMPLETED